CELC

Celcuity LLC is a clinical-stage biotechnology company based in Minneapolis, Minnesota, focused on revolutionizing cancer treatment through its innovative approach to discovering cancer subtypes and targeted therapeutic options. By utilizing its proprietary Celcuity technology platform, the company aims to identify specific biological markers in cancer patients, thereby enabling personalized and more effective treatment strategies. With a robust pipeline of drug candidates and a commitment to advancing precision medicine, Celcuity is well-positioned to address the unmet needs of cancer patients in the United States.